ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CNTX Context Therapeutics Inc

1.41
0.05 (3.68%)
Apr 23 2024 - Closed
Delayed by 15 minutes

Context Therapeutics Financial Summary

The current CNTX market cap is 22.51M. The company's latest EPS is USD -1.5009 and P/E is -0.93.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -4.05M-4.38M-6.67M-5.29M-6.18M
Net Income -3.85M-4.06M-6.31M-5.01M-5.87M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -10.53M-15.88M-25.07M
Net Income -10.46M-15.34M-23.96M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Assets 42.08M37.97M31.97M27.76M22.99M
Total Liabilities 4.01M3.21M3.23M3.76M4.6M
Total Equity 38.07M34.76M28.73M24.01M18.39M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 51.31M37.97M16.06M
Total Liabilities 3.03M3.21M4.19M
Total Equity 48.27M34.76M11.87M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Operating -9.62M-13.55M-5.73M-10.36M-13.82M
Investing -537k-537k N/A N/A N/A
Financing -102k-102k N/A N/A N/A
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -8.8M-13.55M-21.05M
Investing -250k-537k N/A
Financing 58.39M-102k N/A
Market Cap 22.51M
Price to Earnings Ratio -0.93
Price to Sales Ratio 0
Price to Cash Ratio 1.54
Price to Book Ratio 1.87
Dividend Yield -

Share Statistics

Shares Outstanding 15.97M
Average Volume (1 week) 27.17k
Average Volume (1 Month) 80.99k
52 Week Change 135.00%
52 Week High 1.69
52 Week Low 0.47
Spread (Intraday) 0.15 (10.64%)

Company Info

Company Name Context Therapeutics Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.contexttherapeutics.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock